Difference between revisions of "Part:BBa K4140028"
(→Part Description) |
(→Usage) |
||
| Line 13: | Line 13: | ||
We used a brand new platform to deliver our circuit to the targeted tissue by employing the capacity of PEG10 mRNA to be encapsidated by its expressed GAG protein to deliver the mRNA of PAH to hepatocytes through VLPs. | We used a brand new platform to deliver our circuit to the targeted tissue by employing the capacity of PEG10 mRNA to be encapsidated by its expressed GAG protein to deliver the mRNA of PAH to hepatocytes through VLPs. | ||
| − | This was done by adding 5’ and 3’ UTR of PEG10 gene to PAH sequence to guarantee | + | This was done by adding 5’ and 3’ UTR of PEG10 gene to PAH sequence to guarantee its encapsidation with PEG10 proteins |
| − | And we employed VSVg-Fusogen to | + | And we employed VSVg-Fusogen to deliver PAH mRNA to the tissue of interest (hepatocytes) as shown in figure 1. |
[[Image:send.png|right| ]] | [[Image:send.png|right| ]] | ||
Figure(1) SEND delivery to hepatocytes | Figure(1) SEND delivery to hepatocytes | ||
Latest revision as of 04:54, 12 October 2022
SEND delivery device
Part Description
Our delivery system SEND platform which formed of 3 domains the first component PEG10 which is GAG protein forms a capsid or vesicle that incircles its own mRNA and self-assembles into virion-like. The second component : VSVg-Fusogen is a typical type III viral fusion protein that, will mediate the delivery of VLPs to target tissues (hepatocytes). Third component: cargo RNA the RNA needed to be carried by the VLPs which is the mRNA of PAH with the addition of 5’ UTR of PEG10 gene to ensure its encapsidation by PEG10 capsid.
Usage
We used a brand new platform to deliver our circuit to the targeted tissue by employing the capacity of PEG10 mRNA to be encapsidated by its expressed GAG protein to deliver the mRNA of PAH to hepatocytes through VLPs.
This was done by adding 5’ and 3’ UTR of PEG10 gene to PAH sequence to guarantee its encapsidation with PEG10 proteins And we employed VSVg-Fusogen to deliver PAH mRNA to the tissue of interest (hepatocytes) as shown in figure 1.
Figure(1) SEND delivery to hepatocytes
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 1045
Illegal PstI site found at 1747 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1117
Illegal NheI site found at 3526
Illegal PstI site found at 1045
Illegal PstI site found at 1747 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 240
Illegal BglII site found at 3956
Illegal BamHI site found at 477
Illegal BamHI site found at 1160
Illegal BamHI site found at 4483
Illegal XhoI site found at 3306
Illegal XhoI site found at 4193 - 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 1045
Illegal PstI site found at 1747 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 1045
Illegal PstI site found at 1747
Illegal NgoMIV site found at 3117
Illegal AgeI site found at 376 - 1000COMPATIBLE WITH RFC[1000]